Revolution Medicines Inc (NASDAQ:RVMD) traded at $35.96 at close of the session on Friday, April 26, made an upward move of 1.78% on its previous day’s price.
Looking at the stock we see that its previous close was $35.33 . In terms of its 52-week price range, RVMD has a high of $38.73 and a low of $15.44. The company’s stock has gained about 13.37% over that past 30 days.
Revolution Medicines Inc has a market cap of $5.92 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.75, with the EPS growth for the year raised at -$3.19 for 2024 and -$3.43 for next year. These figures represent 17.40% and -7.50% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.44 million, with a high of $8.4 million. The median projection represents growth adding up to -79.50% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $7.58 million, or -34.50% down from figures reported last year.
On the other hand, looking at the outlook for the RVMD stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 4.92% off its SMA20 and 11.86% from its 50-day simple moving average. The RSI (14) is pointing at 58.49 while the volatility over the past week is 4.41% and jumps to 5.28% over the past one month. The beta value is 1.49, while the average true range (ATR) is currently pointing at 1.71.
Coming back to Revolution Medicines Inc (NASDAQ:RVMD), we note that the average 3-month trading volume was 1.46 million. Current shares outstanding are 164.67 million.
The insiders hold 17.12% of the company’s shares while institutions hold 79.15%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 25.38% up in year-to-date price movement.
